# Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

> **NCT07125235** · NA · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 270 (estimated)

## Conditions studied

- Behavioral Intervention
- Viral Suppression of HIV Infection
- ART Adherence

## Interventions

- **BEHAVIORAL:** reSTART Objective Adherence Self-Monitoring and Postive Affect mHealth Intervention
- **DEVICE:** urine tenofovir point-of-care self-test

## Key facts

- **NCT ID:** NCT07125235
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-07-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07125235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07125235, "Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07125235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*